Login to Your Account

New trial enrolled in U.S., too

Aveo Oncology Inc. CEO Michael Bailey told BioWorld that the positive opinion from the EMA's Committee for Medicinal Products for Human Use on approval of Fotivda  in advanced renal cell carcinoma is "really just the beginning" of the drug's revival..

more »

Our Habitat for All Things Science
Clearing senescent cells, restoring progenitor stem cells to reverse age-related disease

SAN DIEGO – Nobody wants to get old. Health declines, disease increases and insurance costs skyrocket. But what if researchers could slow the process at the cellular level, reverting stem cells to their youthful state, or clearing senescent cells, a hallmark of advanced years?

Two companies working in the space presented their research at the BIO convention during a session titled "Reimagine Old Age: New Frontiers in the Science of Aging."

The aging process involves a loss of homeostasis, with messy DNA and reduced gene expression.READ MORE »


Partners in Focus